Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
As filed · Sai Life Sciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
What happened
FactSai Life Sciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company. Sai Life Sciences Limited (CIN: U24110TG1999PLC030970). Phiroze Jeejeebhoy Towers, Dalal Street.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnWe are already in discussions with several large pharmaceutical companies and hope to transition at least two large pharmaceutical customers to integrated models this year.
We are seeing molecules transition through different stages of development.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- We are already in discussions with several large pharmaceutical companies and hope to transition at least two (management committed by FY27)
Evidence
- Sai Life Sciences Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%